阿里斯托洛基酸脏病的概述:一个最新的更新
Qingqing Zhou1,2, Lei Jiang1,2,3, Tao Su1,2,3
1Division of Renal, Department of Medicine, Peking University First Hospital, Beijing, China.
Kidney research and clinical practice
|July 14, 2023
概括
阿里斯托洛基酸病 (AAN) 是一种严重的病,由阿里斯托洛基酸 (AA) 暴露引起. 虽然AAN病例由于草药监管而下降,但有效的治疗方法仍然难以捉摸,需要持续保持警.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 阿里斯托洛希酸脏病 (AAN) 是一种与阿里斯托洛希酸 (AA) 暴露相关的渐进性纤维化.
- 在近30年前被发现后,AAN成为全球健康问题,突出了与草药相关的风险.
- 尽管有进展,但AAN的真实发病率和AA暴露患病率仍然被低估,原因是潜伏性发病.
研究的目的:
- 审查和更新关于阿里斯托洛奇酸病 (AAN) 的当前知识.
- 总结研究进展,了解AAN的毒性,机制,模式和病理学.
- 为了确定未解决的挑战和未来的研究方向AAN.
主要方法:
- 关于阿里斯托洛希克酸病 (AAN) 的综合文献综述.
- 对AA毒性,疾病机制,临床表现和病理学数据的分析.
- 综合有关监管措施的信息及其对AAN发病率的影响.
主要成果:
- 在了解AA毒性和AAN病原性方面取得了重大进展.
- 严格监管含有AA的草药导致报告的AAN病例急剧下降.
- 零星的AAN病例继续发生,对脏恶化的有效治疗仍然缺乏.
结论:
- 阿里斯托洛基酸病 (AAN) 仍然是一个重要的公共卫生问题,需要持续关注.
- 进一步的研究对于解决AAN发病率,暴露和治疗方面的知识差距至关重要.
- 公共卫生工作者和临床医生必须对AA暴露的风险保持警.
相关概念视频
01:26Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
01:30Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
01:24Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
01:30Peripheral Artery Disease I: Introduction
10
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
10
01:29Acute Kidney Injury II: Pathophysiology
34
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
34
01:26Anticholinesterase Agents: Poisoning and Treatment
923
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
923